Report
MarketLine Department
EUR 323.37 For Business Accounts Only

Phylogica Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary

Marketline's Phylogica Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Phylogica Limited since January2007.

Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Phylogica Limited's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Phylogica Limited. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Phylogica Limited's M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Phylogica Limited and its subsidiaries since 2007.
- Information about key financial and legal advisors for Phylogica Limited's financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to Buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Phylogica Limited’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.
Underlyings
Antisense Therapeutics

Antisense Therapeutics is engaged in the research and development of its antisense products, which are under development. Co.'s antisense drugs are designed to bind to a specific messenger RNA sequence with precision and thereby block or stop the production of the disease causing protein in the first instance. Co. operates within the following segments: Multiple Sclerosis; and Growth and Sight Disorders.

Pharmaust

Pharmaust is a drug discovery and development company. Co. develops its own drug discovery intellectual property as well as providing medicinal and synthetic chemistry services on a contract basis to clients. Co.'s subsidiary, Epichem Pty Ltd, provides a range of pharmaceutical impurities, degradants and metabolites of ingredients and excipients, particularly for over the counter and generic drugs.

Pharmaxis Ltd.

Pharmaxis is a pharmaceutical company with a portfolio of products at various stages of development and approval. Co.'s development pipeline is focused in amine oxidase chemistry and includes Semicarbazide-Sensitive Amine Oxidase Inhibitors for Non-alcoholic Steatohepatitis (NASH) and inflammatory diseases including kidney fibrosis and Chronic Obstructive Pulmonary Disease, and Lysyl Oxidase Inhibitors targeting fibrotic diseases including NASH, pulmonary fibrosis and some cancers. Co.'s products include Bronchitol®, an inhaled dry powder for the treatment of cystic fibrosis; and Aridol®, a lung function test for asthma, which is approved and sold in Europe, Australia and Asia.

Provider
MarketLine
MarketLine

MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.

 For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.

 MarketLine’ holistic business intelligence report collection includes:

 Industry Intelligence

‒ Industry Profiles

‒ Market Forecasts

‒ Porter’s Five Forces Analysis

 Company Intelligence

‒ Company Profiles

‒ SWOT Analysis

‒ Financial Deals

 Country and City Intelligence

‒ Country and City Profiles

‒ PEST/PESTLE Analysis

‒ Socio and macro-economic indicators

Analysts
MarketLine Department

Other Reports on these Companies
Other Reports from MarketLine

ResearchPool Subscriptions

Get the most out of your insights

Get in touch